D.A. Davidson & Co’s Recursion Pharmaceuticals RXRX Stock Holding History

D.A. Davidson & Co’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$568K	Buy
2024 Q4	$108K	Sell
2024 Q3	$752K	Buy
2024 Q2	$807K	Buy
2024 Q1	$106K	Buy